共 156 条
[1]
Dahl R(2010)Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD Thorax 65 473-479
[2]
Chung KF(2010)Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium Am J Respir Crit Care Med 182 155-162
[3]
Buhl R(2010)Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study BMC Pulm Med 10 11-279
[4]
Magnussen H(2010)Once-daily indacaterol vs twice-daily salmeterol for COPD: a placebo-controlled comparison Eur Respir J 37 273-171
[5]
Nonikov V(2010)Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design Pulm Pharmacol Ther 23 165-995
[6]
Jack D(2009)Once-daily indacaterol provides effective bronchodilation over 1 year of treatment in patients with chronic obstructive pulmonary disease (COPD) Chest 136 4S-943
[7]
Bleasdale P(2007)Innovative approaches for designing and analyzing adaptive dose-ranging trials J Biopharm Stat 17 965-362
[8]
Owen R(2002)Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Eur Respir J 19 936-66
[9]
Higgins M(1995)Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study Respir Med 89 357-1142
[10]
Kramer B(1995)Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease Thorax 50 62-847